A liquid crystal display device 10 in accordance with the present invention includes a liquid crystal panel 11 and a lighting device 12. These compounds inhibit L-CPT1 and may be used to treat diseases associated with L-CPT1. The system and methods utilize input criteria, which may include the users actively providing a location or environment in which they are or will be located, or can utilize location devices carried by the users to determine the users’ locations or environments. The power line is disposed on the substrate and is configured to provide the integrated circuit unit with power supply on the substrate. The incident excitation radiation is projected onto the sterile matrix through the nail, which operates as a window. The stationary and movable blades have opposed cutting blade parts to each of which a relief angle is imparted.